ライフサイエンスコーパス: allergic rhinitis

1 with known risk factors for asthma, such as allergic rhinitis).

2 henotype was only positively associated with allergic rhinitis.

3 and subsequent wheeze/asthma, eczema and/or allergic rhinitis.

4 ncy may have beneficial effects on childhood allergic rhinitis.

5 were efficacious in treating HDM-associated allergic rhinitis.

6 .53; 1.24-1.89), but was not associated with allergic rhinitis.

7 oxazosin might produce beneficial effects in allergic rhinitis.

8 outcomes were also observed in subjects with allergic rhinitis.

9 stence, comorbidity and evolution similar to allergic rhinitis.

10 on sample and among subjects with asthma and allergic rhinitis.

11 was useful in the severe cases of childhood allergic rhinitis.

12 e and reflects the real-life epidemiology of allergic rhinitis.

13 2.55-7.06) was significantly associated with allergic rhinitis.

14 but no association was found with asthma and allergic rhinitis.

15 sk of any asthma, atopic asthma, wheeze, and allergic rhinitis.

16 in vivo allergen challenge of patients with allergic rhinitis.

17 heeze and eczema were stronger predictors of allergic rhinitis.

18 later followed by food allergy, asthma, and allergic rhinitis.

19 ouse dust mite (HDM) extracts in adults with allergic rhinitis.

20 years, 9% of men and 15% of women developed allergic rhinitis.

21 the first report of age at onset effects in allergic rhinitis.

22 veness predicted new-onset asthma, COPD, and allergic rhinitis.

23 or combination pharmacotherapy for seasonal allergic rhinitis.

24 ntradermal immunotherapy in the treatment of allergic rhinitis.

25 ch, which includes food allergy, asthma, and allergic rhinitis.

26 k of asthma, aeroallergen sensitization, and allergic rhinitis.

27 eous immunotherapy are effective in seasonal allergic rhinitis.

28 nd an apparent reduction in the incidence of allergic rhinitis.

29 m 25(OH)D levels at any time point with ever allergic rhinitis.

30 ng patients with moderate to severe seasonal allergic rhinitis, 2 years of sublingual grass pollen im

31 estigating the efficacy of SLIT for seasonal allergic rhinitis (2009-2013) were selected for review.

32 Most common comorbidities were allergic rhinitis (62.4%), gastroesophageal reflux (42.1

33 We retrieved 97 studies on allergic rhinitis, 91 on allergic dermatitis, and eight

34 osity-asthma association in this population: allergic rhinitis accounted for 22% to 53% of the associ

35 was higher in subjects who had parents with allergic rhinitis (adjusted HR, 2.24 [95% CI, 1.67-3.02]

36 obesity was associated with reduced odds of allergic rhinitis (adjusted odds ratio, 0.35; 95% CI, 0.

37 0 [95% CI, -1.55 to -0.06]; P = 0.0348), and allergic rhinitis (adjusted odds ratio, 4.83 [95% CI, 1.

38 Allergic rhinitis affects approximately one in four of t

39 en immunotherapy (AIT) for the management of allergic rhinitis, allergic asthma, IgE-mediated food al

40 o allergic conditions (food allergy, asthma, allergic rhinitis, allergic conjunctivitis, and eosinoph

41 Allergic rhinitis, allergic dermatitis, and food allergy

42 Non-allergic rhinitis also is a risk factor for the developm

43 o play different roles in the development of allergic rhinitis among men and women.

44 20 (7.5%) found exclusively in patients with allergic rhinitis and 25 (9.5%) found exclusively in hea

45 d associations of residential greenness with allergic rhinitis and aeroallergen sensitization based o

46 ness appears to be associated with childhood allergic rhinitis and aeroallergen sensitization, the ef

47 The number of genes related to allergic rhinitis and allergic asthma increases steadily

48 ly disease-modifying treatment available for allergic rhinitis and allergic asthma.

49 ations for the exploration of biomarkers for allergic rhinitis and allergic asthma.

50 l allergen source and a significant cause of allergic rhinitis and allergic asthma.

51 m the house dust mite and is associated with allergic rhinitis and allergic asthma.

52 and ascertain its association with childhood allergic rhinitis and allergic sensitization.

53 tly reported associations with self-reported allergic rhinitis and allergic sensitization.

54 reatment was well tolerated in patients with allergic rhinitis and appears to reduce allergic respons

55 questionnaire to determine the prevalence of allergic rhinitis and asked about sociodemographics and

56 Allergic rhinitis and asthma constitute two clinical exp

57 i.e. the Allergy Diary and CARAT: Control of Allergic Rhinitis and Asthma Test) in 22 Reference Sites

58 ed allergic diseases, including respiratory (allergic rhinitis and asthma) and skin (atopic dermatiti

59 It is widely believed that in patients with allergic rhinitis and asthma, avoidance of specific trig

60 It is widely believed that for allergic rhinitis and asthma, avoidance of specific trig

61 M allergens is crucial in the development of allergic rhinitis and asthma, but the translation of sil

62 blets has been demonstrated in patients with allergic rhinitis and asthma.

63 is effective in patients with IgE-dependent allergic rhinitis and asthma.

64 ociated with asthma phenotypes with comorbid allergic rhinitis and atopic dermatitis.

65 rst App (iOS and Android) to have tested for allergic rhinitis and conjunctivitis.

66 UFAs were associated with increased risks of allergic rhinitis and eczema up to 18 years, and sensiti

67 has variable preventative effects on asthma, allergic rhinitis and eczema up to adolescence.

68 The results for allergic rhinitis and eczema were less consistent.

69 cularly prevalent in those with early onset, allergic rhinitis and hand eczema in childhood.

70 antly associated with early onset, childhood allergic rhinitis and hand eczema.

71 outcomes (asthma, wheeze, atopic dermatitis, allergic rhinitis and IgE) were assessed across the stud

72 llergy and Asthma European Network (Ga2len), Allergic Rhinitis and Its Impact on Asthma (ARIA), and t

73 In view of the Allergic Rhinitis and its Impact on Asthma group's call

74 technologies in rhinitis control, the ARIA (Allergic Rhinitis and its Impact on Asthma) score rangin

75 , while the effect is mainly confined to non-allergic rhinitis and more pronounced in adolescents tha

76 tion pilot study, 18 subjects with perennial allergic rhinitis and sensitization to HDM were exposed

77 g allergy symptoms in patients with seasonal allergic rhinitis and that it is well tolerated.

78 e QOL questionnaire sheets for children with allergic rhinitis and their parents.

79 e TennCare population who had a diagnosis of allergic rhinitis and who then initiated the use of leuk

80 eczema, childhood wheeze/asthma, eczema and allergic rhinitis and young adult asthma.

81 Asthma, hay fever (or allergic rhinitis) and eczema (or atopic dermatitis) oft

82 importance of mold exposure in patients with allergic rhinitis, and a new immunologic classification

83 Atopic dermatitis (AD), food allergy, allergic rhinitis, and asthma are common atopic disorder

84 .9 years), we assessed food allergy, asthma, allergic rhinitis, and atopic dermatitis by questionnair

85 nically as atopic diseases including asthma, allergic rhinitis, and atopic dermatitis.

86 Yearly childhood asthma, allergic rhinitis, and eczema diagnoses were longitudina

87 platelet activation in patients with asthma, allergic rhinitis, and eczema.

88 lets in allergic diseases, including asthma, allergic rhinitis, and eczema.

89 hyperreactivity (BHR), flexural eczema (FE), allergic rhinitis, and sensitization in childhood and ea

90 in eosinophilic diseases such as asthma and allergic rhinitis, and the OXE receptor, which mediates

91 to treat allergic diseases, such as asthma, allergic rhinitis, and venom allergy, since first descri

92 ssociated with an increased risk of incident allergic rhinitis (AOR 2.55; 95% CI 1.01-6.49); each 25

93 K-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) App (Allergy Diary) assesses allergic

94 K-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) app (Allergy Diary) on smartphones sc

95 children with asthma, atopic dermatitis, and allergic rhinitis appears less likely to be driven by al

96 Allergic rhinitis (AR) (P = 0.016), persistent AR (P = 0

97 Allergic rhinitis (AR) affects up to 30% of the adult po

98 Phenotypic evaluation of allergic rhinitis (AR) and allergic sensitization was pe

99 Allergic rhinitis (AR) and asthma are common allergic co

100 thin existing adult treatment algorithms for allergic rhinitis (AR) and chronic rhinosinusitis (CRS).

101 parent-reported physician-diagnosed asthma, allergic rhinitis (AR) and eczema, as well as spirometri

102 vitamin D at age 8 years and development of allergic rhinitis (AR) and nonallergic rhinitis (NAR) be

103 Baseline allergic rhinitis (AR) and peanut SPT wheal size were si

104 immunotherapy is effective in patients with allergic rhinitis (AR) and, unlike antiallergic drugs, h

105 mmunotherapy (AIT) is the only treatment for allergic rhinitis (AR) and/or allergic asthma (AA) with

106 Asthma and allergic rhinitis (AR) are common allergic comorbidities

107 lection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several factors, inclu

108 on of all 10 TLR genes for associations with allergic rhinitis (AR) detected a number of significant

109 lted in a decreased probability of having an allergic rhinitis (AR) exacerbation day (from 11% [place

110 f immunotherapy on bronchial asthma (BA) and allergic rhinitis (AR) in Japanese children.

111 Allergic rhinitis (AR) is a common chronic disease, whic

112 Allergic rhinitis (AR) is a main risk factor for the dev

113 Allergic rhinitis (AR) is characterized by mucosal infla

114 Allergic rhinitis (AR) is one of the most common chronic

115 es research on medical care and treatment of allergic rhinitis (AR) is scarce.

116 sidered the first step in the development of allergic rhinitis (AR) or an independent phenotype.

117 the 1p31 region to the combined asthma plus allergic rhinitis (AR) phenotype.

118 patients consulting for grass-pollen-induced allergic rhinitis (AR) recorded a 15-point global rating

119 Diagnoses of current allergic rhinitis (AR) related to mite allergy and asthm

120 , clinical characteristics, and treatment of allergic rhinitis (AR) symptoms in the first year of lif

121 allergen challenge (NAC) is a human model of allergic rhinitis (AR) that delivers standardized allerg

122 sociation between periodontitis and previous allergic rhinitis (AR) using a matched patient-control s

123 Allergic rhinitis (AR) was defined as one or more positi

124 (IGH) repertoires in patients with seasonal allergic rhinitis (AR) with the aim of better understand

125 Guidelines on the treatment of asthma, allergic rhinitis (AR), and allergen immunotherapy (AIT)

126 Symptoms of allergic rhinitis (AR), asthma, and allergic dermatitis

127 ion is affected by allergic diseases such as allergic rhinitis (AR), atopic dermatitis (AD) and aller

128 Allergic rhinitis (AR), chronic rhinosinusitis (CRS) and

129 cts with allergic asthma (AA), subjects with allergic rhinitis (AR), or healthy control (HC) subjects

130 icant impairment of quality of life (QoL) in allergic rhinitis (AR), the degree of impairment in QoL

131 Despite the socioeconomic importance of allergic rhinitis (AR), very few prospective studies hav

132 (both 1 spray/nostril bid), in children with allergic rhinitis (AR).

133 allergic inflammation seen in patients with allergic rhinitis (AR).

134 n adults with moderate-to-severe HDM-induced allergic rhinitis (AR).

135 kers to diagnose and characterize asthma and allergic rhinitis (AR).

136 ithelial TJs remain unknown in patients with allergic rhinitis (AR).

137 ers to be efficacious in preventing seasonal allergic rhinitis (AR).

138 ysfunction is a key symptom in patients with allergic rhinitis (AR).

139 polysensitized patients with pollen-related allergic rhinitis (AR).

140 new therapeutic targets and/or biomarkers of allergic rhinitis (AR).

141 pinnings associated with the pathogenesis of allergic rhinitis are not entirely clear.

142 tions related to the treatment of asthma and allergic rhinitis as primary outcomes.

143 i-inflammatory responses in animal models of allergic rhinitis, asthma, chronic obstructive pulmonary

144 utism, and the Necator americanus larvae for allergic rhinitis, asthma, coeliac disease, and multiple

145 ified from four recent systematic reviews on allergic rhinitis, asthma, food allergy and venom allerg

146 eases, with strong associations observed for allergic rhinitis at 12 (OR = 5.69[95% CI: 1.83,17.60] p

147 adjusted OR 3.45, 95% CI 1.07-11.74), as was allergic rhinitis at 5-7 years of age (adjusted OR 4.06,

148 500-m buffer was positively associated with allergic rhinitis at 6-8 years in BAMSE (odds ratio = 1.

149 valence of food allergy, asthma, eczema, and allergic rhinitis at age 4 years.

150 een cord serum 25(OH)D levels and asthma and allergic rhinitis at age 5 years.

151 ) or with current eczema, wheeze/asthma, and allergic rhinitis at age 7 years (OR, 1.07 [95% CI, 0.92

152 of a child developing asthma, eczema, and/or allergic rhinitis at ages 6 or 14 years, depending on ma

153 Among 1351 adults who did not report allergic rhinitis at baseline, incident allergic rhiniti

154 ciated with 21% and 20% reduced odds of ever allergic rhinitis at school age (odds ratios of 0.79 [95

155 hogenic in allergic diseases such as asthma, allergic rhinitis, atopic dermatitis, and food allergy.

156 Allergic rhinitis, atopic eczema and food hypersensitivi

157 For allergic rhinitis, authors focused on the prediction of

158 Here, we describe in patients with allergic rhinitis B cells with a memory phenotype respon

159 idic solution that discriminates asthma from allergic rhinitis based on a patient's neutrophil chemot

160 associated with inflammatory responses as in allergic rhinitis but can also occur in the absence of i

161 ersity was associated with increased risk of allergic rhinitis but not with the other end points.

162 age, gender, presence of symptoms of asthma, allergic rhinitis, chronic rhinosinusitis, smoking statu

163 nal linkage of the 4q35 region to asthma and allergic rhinitis comorbidity (AAR; P = 7.2 x 10(-5)).

164 Mobile technology has been used to appraise allergic rhinitis control, but more data are needed.

165 However, a large majority of subjects with allergic rhinitis do not develop asthma, suggesting dive

166 Allergic rhinitis (doctor diagnosis/symptoms) and aeroal

167 fector cells in allergic diseases, including allergic rhinitis, eczema, and asthma.

168 diagnosis and management of allergic and non-allergic rhinitis, first published in 2007.

169 Main Outcomes and Measures: Wheeze, eczema, allergic rhinitis, food allergy, allergic sensitization,

170 ns resulting in conditions including asthma, allergic rhinitis, food allergy, and atopic dermatitis.

171 3 years, children were assessed for asthma, allergic rhinitis, food allergy, and atopic dermatitis.

172 year of life and the development of asthma, allergic rhinitis, food allergy, or atopic sensitization

173 ptomatic or have signs and symptoms, such as allergic rhinitis, for which the relationship to periphe

174 combining asthma, atopic dermatitis, and/or allergic rhinitis from 10 to 16 years, stratifying for a

175 e key research advances made in the field of allergic rhinitis from 2013 to 2015.

176 dren (defined as children with asthma and/or allergic rhinitis) from Fresno, California, an area with

177 al immunotherapy tablets in the treatment of allergic rhinitis has been firmly established in large m

178 Sublingual immunotherapy for allergic rhinitis has been used successfully for years i

179 Research efforts in allergic rhinitis have always been intense.

180 etween allergic sensitization and asthma and allergic rhinitis in adults are scarce.

181 or central obesity were not associated with allergic rhinitis in adults.

182 -hydroxyvitamin D [25(OH)D] and incidence of allergic rhinitis in adults.

183 opic dermatitis during infancy to asthma and allergic rhinitis in later childhood.

184 n impact on the development of asthma and/or allergic rhinitis in later life.

185 initial pharmacologic treatment of seasonal allergic rhinitis in patients aged 12 years or older.

186 ndation 1: For initial treatment of seasonal allergic rhinitis in persons aged 12 years or older, rou

187 For treatment of moderate to severe seasonal allergic rhinitis in persons aged 12 years or older, the

188 ndation 2: For initial treatment of seasonal allergic rhinitis in persons aged 15 years or older, rec

189 e are few published studies on prevalence of allergic rhinitis in preschool children.

190 most frequently pollens that induce seasonal allergic rhinitis in Spain.

191 The occurrence of so-called local allergic rhinitis in the absence of systemic IgE will be

192 rapy provides a new option for patients with allergic rhinitis in the United States.

193 xamined whether having pollinosis (a form of allergic rhinitis) in a follow-up survey could predict a

194 reatest risk of developing asthma, COPD, and allergic rhinitis (incidence rate ratios of 10.82, 5.53,

195 Rates of current asthma and allergic rhinitis increased, whereas the rate of wheezin

196 In allergic rhinitis, initial allergen exposure and sensiti

197 lt patients with moderate to severe seasonal allergic rhinitis (interfering with usual daily activiti

198 Allergic rhinitis is a disease with a high global diseas

199 Allergic rhinitis is common and affects 10-15% of childr

200 Allergic rhinitis is diagnosed by history and examinatio

201 The prevalence of allergic rhinitis is high, but the role of environmental

202 notherapy as compared to pharmacotherapy for allergic rhinitis is the long-term effect that persists

203 f low vitamin D status in the development of allergic rhinitis is unclear.

204 ubjects with moderate-to-severe grass pollen-allergic rhinitis just before beginning and after up-dos

205 cts of allergen immunotherapy (AIT) on local allergic rhinitis (LAR) are largely unknown.

206 Local allergic rhinitis (LAR) is a common disease that affects

207 Local allergic rhinitis (LAR) is characterized by the presence

208 knowledge about the natural history of local allergic rhinitis (LAR) is limited.

209 nd have defined a new phenotype called local allergic rhinitis (LAR) or 'entopy'.

210 shown to be an effective treatment for local allergic rhinitis (LAR) to house dust mites.

211 Non-allergic rhinitis may be a presenting complaint for syst

212 contrast to asthma, targeting remodeling in allergic rhinitis may not be appropriate as a therapeuti

213 , when used in patients with both asthma and allergic rhinitis, may be cost-effective with an increme

214 The probability of having had allergic rhinitis medication prescribed was also reduced

215 There was no association between KCN and allergic rhinitis, mitral valve disorder, aortic aneurys

216 The allergic rhinitis mucus proteome shows an enhanced immun

217 ssay 34 asthmatic (n = 23) and nonasthmatic, allergic rhinitis (n = 11) patients to establish domains

218 ntreated subjects with seasonal grass-pollen allergic rhinitis (n = 14) compared with immunotherapy-t

219 d by analyzing its proteome in patients with allergic rhinitis (n = 29) and healthy control subjects

220 on with patients suffering from IgE-mediated allergic rhinitis (n=10) and healthy controls (n=10).

221 Participants with allergic rhinitis (n=42) were randomized to receive eigh

222 nvestigated the cost-effectiveness of AIT in allergic rhinitis, of which seven were based on data fro

223 Allergic rhinitis often impairs social life and performa

224 y promote these biomarkers to become part of allergic rhinitis or allergic asthma classifiers with hi

225 y participant report of having or having had allergic rhinitis or hay fever at follow-up.

226 ced asthma (OR, 0.83; 95% CI, 0.69-0.99) and allergic rhinitis (OR, 0.85; 95% CI, 0.74-0.97).

227 served atopic march from early AD to asthma, allergic rhinitis, or both later in life and the extensi

228 econdary outcomes were prevalence of eczema, allergic rhinitis, or other atopic conditions.

229 sed childhood asthma, atopic dermatitis, and allergic rhinitis (ORs, 3.6 to 8.1).

230 such remodeling in patients with persistent allergic rhinitis (PAR) is unknown.

231 Perennial allergic rhinitis (PAR) represents a global and public h

232 asonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR).

233 In PBMCs of allergic rhinitis participants, 42 sites showed signific

234 urbance, and treatment agents, for childhood allergic rhinitis patients under age 12.

235 Fifteen allergic rhinitis patients with grass pollen allergy and

236 In blood of allergic rhinitis patients with high serum IgE to grass

237 vaccines in vitro and in allergen-SIT of cat-allergic rhinitis patients, who received 3 inguinal intr

238 d in monocytes and eosinophils obtained from allergic rhinitis patients.

239 AS) is a validated tool to assess control in allergic rhinitis patients.

240 ve" of respiratory allergy, i.e., asthma and allergic rhinitis, plaguing westernized countries, with

241 , eczema (pooled OR 2.7; 95% CI 1.7-4.4) and allergic rhinitis (pooled OR 3.1; 95% CI 1.9-4.9) from 4

242 Allergic rhinitis prevalence was similar in all groups (

243 Forty-one patients with allergic rhinitis received idelalisib/placebo (n = 21) o

244 design trial, 37 participants with seasonal allergic rhinitis received suboptimal SCIT (30,000 stand

245 l obesity is associated with reduced odds of allergic rhinitis, regardless of sex.

246 T)-tablets with pharmacotherapy for seasonal allergic rhinitis (SAR) and perennial allergic rhinitis

247 solved diagnostics in patients with seasonal allergic rhinitis (SAR) and positive skin prick test to

248 Seasonal allergic rhinitis (SAR) caused by intermittent exposure

249 Seasonal allergic rhinitis (SAR) is a disease of increasing preva

250 lammatory response in patients with seasonal allergic rhinitis (SAR) is partly mediated by the prosta

251 In previous research, patients with seasonal allergic rhinitis (SAR) showed poorer school and work pe

252 up; n = 6), patients with untreated seasonal allergic rhinitis (SAR; n = 24), and nonatopic control s

253 nonallergic inflammatory diseases, including allergic rhinitis, sepsis, atherosclerotic disease, and

254 iations between vitamin D exposure with ever allergic rhinitis, serum total IgE level, and allergen s

255 Our data indicate that the collection of allergic rhinitis symptom data by 'citizen science' is f

256 gy Diary) on smartphones screens to evaluate allergic rhinitis symptoms and disease control.

257 asal responses in some patients with typical allergic rhinitis symptoms but without atopy and have de

258 ergic rhinitis) App (Allergy Diary) assesses allergic rhinitis symptoms, disease control and impact o

259 urvey to monitor spatiotemporal variation in allergic rhinitis symptoms.

260 -mediated food allergy, allergic asthma, and allergic rhinitis that begins with an atopic family hist

261 est novel concepts and research questions in allergic rhinitis that may not be identified using class

262 The risk factors for asthma (e.g., allergic rhinitis) that were identified either by NLP or

263 Male gender, allergic rhinitis, the presence of dysphagia, and younge

264 -related class 10 (PR-10) protein family and allergic rhinitis to birch pollen (ARbp) from early chil

265 assigned 93 adults with grass pollen-induced allergic rhinitis to receive 7 preseasonal intradermal a

266 The Gauging Response in Allergic Rhinitis to Sublingual and Subcutaneous Immunot

267 rify the present conditions of the childhood allergic rhinitis treatment in many departments of otorh

268 he clinical development programs of selected allergic rhinitis treatments were evaluated.

269 Twelve participants with seasonal allergic rhinitis underwent a control (diluent) challeng

270 ng nasal allergen challenge in subjects with allergic rhinitis using novel noninvasive methodology.

271 ic diseases: 53% of children with asthma had allergic rhinitis vs. 15% in those without asthma (P < 0

272 Overall prevalence of allergic rhinitis was 18% (95% CI 16% to 20%).

273 When stratified by site, the prevalence of allergic rhinitis was 23% Lima vs. 13% in Tumbes (P < 0.

274 In children and adolescent, allergic rhinitis was associated with active (pooled RR,

275 ssociated with asthma across all age groups; allergic rhinitis was associated with sensitization to b

276 Allergic rhinitis was defined as physician-diagnosed hay

277 port allergic rhinitis at baseline, incident allergic rhinitis was identified by participant report o

278 The prevalence of allergic rhinitis was increased, particularly among youn

279 ole of nasal mucus in the pathophysiology of allergic rhinitis was investigated by analyzing its prot

280 del results and pooled ORs expressed as RR), allergic rhinitis was not associated with active smoking

281 Allergic rhinitis was prevalent in both settings, and im

282 l allergies, including hay fever?" (defining allergic rhinitis) was given by 23.2% of men and 25.4% o

283 n attributable risk of important factors for allergic rhinitis were 25% for high exhaled nitric oxide

284 Data on asthma, eczema, and allergic rhinitis were captured by validated Internation

285 Symptoms of allergic rhinitis were controlled (VAS-global <20) in ap

286 Eczema, wheeze/asthma, and allergic rhinitis were diagnosed at the Copenhagen Prosp

287 Asthma and allergic rhinitis were diagnosed based on predefined alg

288 uble-blind study, adults with HDM-associated allergic rhinitis were given a daily sublingual tablet c

289 Asthma, wheeze, atopic eczema, and allergic rhinitis were measured by using the Internation

290 Important risk factors for allergic rhinitis were parental rhinitis (adjusted OR =

291 Adults with HDM-associated allergic rhinitis were randomized in a double-blind, pla

292 icosteroids, and can control both asthma and allergic rhinitis when given in recommended doses.

293 ether or not remodelling may be a feature of allergic rhinitis will be reviewed.

294 at AIT may be cost-effective for people with allergic rhinitis with or without asthma and in high-ris

295 ty-two adult patients (19-61 years old) with allergic rhinitis with or without asthma caused by grass

296 in North American subjects with HDM-induced allergic rhinitis with or without conjunctivitis (AR/C).

297 , single-site trial, adults with HDM-induced allergic rhinitis with or without conjunctivitis and wit

298 unotherapy for house dust mite (HDM)-induced allergic rhinitis with or without conjunctivitis is unce

299 a consistent entity that does not evolve to allergic rhinitis with systemic atopy over time although

300 trials of grass SLIT-tablet in subjects with allergic rhinitis with/without conjunctivitis (AR/C), AE